Epidrug Screening Identifies Type I PRMT Inhibitors as Modulators of Lysosomal Exocytosis and Drug Sensitivity in Cancers
Baris Sergi, Neslihan Yuksel-Catal, Selahattin Can Özcan…·Ceyda Acilan
This paper screens epigenetic drugs to identify Type I PRMT inhibitors that inhibit lysosomal exocytosis and enhance chemotherapy efficacy in cancer.